517. Safety and Tolerability of Intramuscular (IM) Sotrovimab 500 mg Administered at Different Injection Sites: Results from the Phase I COSMIC Study

por Moore, Jennifer, Chen, Wen-Hung, Daniluk, Jerzy, Parra, Sergio, Turner, Megan, Sanchez-Pearson, Yasmin, Sakar, Prosenjit, Hawes, Ian A, Aylott, Alicia
Publicado 2023

Violation of the 12/23 rule of genomic V(D)J recombination is common in lymphocytes

por Parkinson, Nicholas J., Roddis, Matthew, Ferneyhough, Ben, Zhang, Gang, Marsden, Adam J., Maslau, Siarhei, Sanchez-Pearson, Yasmin, Barthlott, Thomas, Humphreys, Ian R., Ladell, Kristin, Price, David A., Ponting, Chris P., Hollander, Georg, Fischer, Michael D.
Publicado 2015